Oruka Therapeutics, Inc. ORKA Increase (decrease) in other assets
Increase (decrease) in other assets at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherNoncurrentAssets.
The official record: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oruka Therapeutics, Inc.'s increase (decrease) in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oruka Therapeutics, Inc.'s increase (decrease) in other assets?
- Oruka Therapeutics, Inc. (ORKA) reported increase (decrease) in other assets of $60K in Q1 2025.
- What is the long-term trend for Oruka Therapeutics, Inc.'s increase (decrease) in other assets?
- Over 2 years (2021 to 2023), Oruka Therapeutics, Inc.'s increase (decrease) in other assets has grown at a 0.0% compound annual growth rate (CAGR), from $6K to -$6K.
- What does increase (decrease) in other assets mean?
- Tracks the net change in long-term assets that are not classified as property, plant, or equipment. This can include changes in long-term deposits, intangible assets, or other non-current investments. Monitoring this helps identify shifts in the company's long-term asset base and capital deployment strategy.